According to DataM Intelligence, the neuromuscular disease therapeutics market grew from US$ 11.89 B in 2023 to US$ 13.70 B in 2024, and is projected to hit US$ 45.62 B by 2033, driven by gene therapies and RNA-based drugs https://finance.yahoo.com/news/neuromuscular-disease-therapeutics-market-reach-152000966.html